Mitsubishi Tanabe Pharma Corporation
In research, Mitsubishi Tanabe Pharma Corporation stands highest in Medicine (#4,140 of 14,558 worldwide), Health Sciences (#4,772 of 16,688 worldwide) and Life Sciences (#3,523 of 11,023 worldwide), over all time.
- World rank, all time
- #13,418 of 34,923
- Rank in ??
- #142 of 615
- Research works
- 327 ▼ 25% vs 2018-21
- Citations
- 9.3k 28.3 per fractional work
- Top-10% rate
- 7.7% all institutions 10.0%
- vs its own fields
- 0.94× 1.00× is exactly expected
- Open access
- 60% world 40%
- International
- 12% world 18%
What is Mitsubishi Tanabe Pharma Corporation known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #4,140 of 14,558 | 10.7% | 149 | |
| Health SciencesDomain | #4,772 of 16,688 | 10.5% | 152 | |
| Life SciencesDomain | #3,523 of 11,023 | 7.4% | 128 |
Each strip is that field's whole ranked pool, with the notch where Mitsubishi Tanabe Pharma Corporation sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Mitsubishi Tanabe Pharma Corporation work in?
In 2022-now, 53% of research at Mitsubishi Tanabe Pharma Corporation is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (51%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (6%). It does 2.3× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 21 fields, with their numbers
- Health Sciences3052.8%
- Medicine2950.6%
- Nursing11.7%
- Veterinary00.3%
- Health Professions00.3%
- Life Sciences2137.1%
- Physical Sciences58.9%
- Chemistry23.4%
- Computer Science23.3%
- Materials Science10.9%
- Mathematics00.6%
- Engineering00.4%
- Environmental Science00.1%
- Earth and Planetary Sciences00.1%
- Social Sciences11.2%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.1×. Every wedge is a field page.
All 21 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics7.10×1 works
- Immunology and Microbiology6.18×4 works
- Biochemistry, Genetics and Molecular Biology4.68×14 works
- Nursing3.41×1 works
- Medicine2.63×29 works
- Veterinary2.37×0 works
- Chemistry2.16×2 works
- Neuroscience2.01×2 works
- Mathematics0.48×0 works
- Computer Science0.43×2 works
- Materials Science0.27×0 works
- Decision Sciences0.23×0 works
- Economics, Econometrics and Finance0.12×0 works
- Health Professions0.10×0 works
- Earth and Planetary Sciences0.08×0 works
- Psychology0.05×0 works
- Social Sciences0.05×0 works
- Engineering0.03×0 works
- Environmental Science0.03×0 works
- Agricultural and Biological Sciences0.02×0 works
- Business, Management and Accounting0.02×0 works
- Pharmacology, Toxicology and Pharmaceutics 7.1×
- Immunology and Microbiology 6.2×
- Biochemistry, Genetics and Molecular Biology 4.7×
- Nursing 3.4×
- Medicine 2.6×
- Veterinary 2.4×
- Chemistry 2.2×
- Neuroscience 2.0×
- Mathematics 0.5×
- Computer Science 0.4×
- Materials Science 0.3×
- Decision Sciences 0.2×
- Economics, Econometrics and Finance 0.1×
- Health Professions 0.1×
- Earth and Planetary Sciences 0.1×
- Psychology 0.1×
- Social Sciences 0.1×
- Engineering 0.0×
- Environmental Science 0.0×
- Agricultural and Biological Sciences 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Mitsubishi Tanabe Pharma Corporation?
Ranked on the quality score, Kenji Chiba, Toru Yoshinari and Rikiya Ohashi lead among researchers whose main affiliation is Mitsubishi Tanabe Pharma Corporation.
- 1 Kenji Chiba #576,759 worldwide 6.3k citations · 128 works
- 2 Toru Yoshinari #749,533 worldwide 1.1k citations · 32 works
- 3 Rikiya Ohashi #775,008 worldwide 3.5k citations · 58 works
- 4 Satoshi Yuki #942,315 worldwide 2.3k citations · 38 works
- 5 Takuma Tsuchida #1,046,902 worldwide 4k citations · 16 works
- 6 Hirotoshi Kataoka #1,049,109 worldwide 2k citations · 32 works
- 7 Kenji Arakawa #1,167,243 worldwide 1.7k citations · 40 works
- 8 Kiichiro Ueta #1,213,973 worldwide 2.3k citations · 42 works
- 9 Tsuyoshi Suzuki #1,504,271 worldwide 1.9k citations · 55 works
- 10 Kunio Sugahara #1,553,176 worldwide 1.9k citations · 70 works
Which keywords describe research at Mitsubishi Tanabe Pharma Corporation?
By fractional works in 2022-now, weighted toward what it does more of than the world: Genetics, Neurodegeneration, Inflammation, Autoantibodies, Cardiovascular Disease, Medicinal Chemistry, Pharmacokinetics and Treatment.
- Toll-like Receptors
- Drug Design
- Anemia
- Parkinson's Disease
- Stroke
- Endothelial Dysfunction
- Drug Discovery
- Capacity Building
- Virtual Screening
- Molecular Docking
- Diabetes
- Cancer Treatment
- Diagnostic Criteria
- TDP-43
- FUS/TLS
- Cancer
- Autoantibodies
- Oxidative Stress
- Neurodegeneration
- Genetics
- Inflammation
- Epidemiology
- Cardiovascular Disease
- Treatment
- Medicinal Chemistry
- Pharmacokinetics
- Metabolic Syndrome
- Mitochondrial Dysfunction
- Heart Failure
- Chronic Kidney Disease
- Fibrosis
- Neuroprotection
- Liver Transplantation
- TGF-ß
- Immunosuppressive Therapy
- Hypertension
- Autoimmunity
- TGF-ß Signaling
- Antisense Oligonucleotides
- Iron Deficiency
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation4▲ 3.7×26 topics
- Genetics4▲ 9.8×8 topics
- Epidemiology4▲ 1.55×21 topics
- Neurodegeneration4▲ 20×6 topics
- Cardiovascular Disease3▲ 5.0×13 topics
- Oxidative Stress3▲ 3.5×12 topics
- Treatment3▲ 4.3×10 topics
- Autoantibodies3▲ 21×5 topics
- Medicinal Chemistry2▲ 16×4 topics
- Cancer2▲ 3.1×14 topics
- Pharmacokinetics2▲ 15×2 topics
- FUS/TLS2▲ 163×1 topic
- Metabolic Syndrome2▲ 4.7×7 topics
- TDP-432▲ 163×1 topic
- Mitochondrial Dysfunction2▲ 13×6 topics
- Diagnostic Criteria2▲ 15×3 topics
- Heart Failure2▲ 7.9×5 topics
- Cancer Treatment2▲ 14×4 topics
- Chronic Kidney Disease2▲ 14×6 topics
- Diabetes2▲ 5.9×8 topics
- Fibrosis2▲ 15×6 topics
- Molecular Docking2▲ 24×1 topic
- Neuroprotection2▲ 8.7×5 topics
- Virtual Screening2▲ 33×1 topic
- Liver Transplantation2▲ 23×3 topics
- Capacity Building2▲ 45×2 topics
- TGF-ß2▲ 17×4 topics
- Drug Discovery1▲ 11×6 topics
- Immunosuppressive Therapy1▲ 13×3 topics
- Endothelial Dysfunction1▲ 10×5 topics
- Hypertension1▲ 8.0×5 topics
- Stroke1▲ 14×3 topics
- Autoimmunity1▲ 14×3 topics
- Parkinson's Disease1▲ 8.6×6 topics
- TGF-ß Signaling1▲ 30×3 topics
- Anemia1▲ 20×2 topics
- Antisense Oligonucleotides1▲ 47×2 topics
- Drug Design1▲ 29×2 topics
- Iron Deficiency1▲ 38×2 topics
- Toll-like Receptors1▲ 18×2 topics
Which research topics does Mitsubishi Tanabe Pharma Corporation publish most on?
By volume in 2022-now: Amyotrophic Lateral Sclerosis Research, Computational Drug Discovery Methods, Biotechnology and Related Fields and Systemic Lupus Erythematosus Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Amyotrophic Lateral Sclerosis Research Neurology 2 works
- 2 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
- 3 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
- 4 Systemic Lupus Erythematosus Research Rheumatology 1 works
- 5 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works
- 6 Erythropoietin and Anemia Treatment Hematology 1 works
- 7 Parkinson's Disease Mechanisms and Treatments Neurology 1 works
- 8 T-cell and B-cell Immunology Immunology 1 works
- 9 Biochemical Analysis and Sensing Techniques Nutrition and Dietetics 1 works
- 10 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Mitsubishi Tanabe Pharma Corporation's research output changed?
Output in 2022-2025 was 25% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Mitsubishi Tanabe Pharma Corporation as a percentage of every work published that year, 0.00028% in 2024.
Fractional works of Mitsubishi Tanabe Pharma Corporation over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 17.2% in 2019.
Other research institutions in Osaka
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Mitsubishi Tanabe Pharma Corporation. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
